Complex Biologics CDMO+ CRO - Abzena

Awards & Achievements

Celebrating our passion for scientific innovation.

Download Brochure

At Abzena, we are proud to have been recognized for our growth and achievements – we could not do those without the support of our customers. Thank you.

Each award and recognition is a testament to our biologic services, our values, our colleagues, and to our dedication of working with our partners and customers.

Abzena recognized as Best Novel Treatment Development Partner 2024 by GHP

Abzena was honored to be recognized as the Best Novel Treatment Development Partner 2024 in California by the 2024 Global Excellence Awards.

Learn More

Abzena Recognized as Top CDMO in 2024 by Pharma Tech Outlook

Abzena was recently named one of the Top 10 Contract Manufacturing Organizations in 2024 for its substantial contributions to the progression of the CDMO sector by Pharma Tech Outlook magazine.

Learn More

Abzena Recognized as Best Performing R&D Service Provider of the Year by One Nucleus

One Nucleus recognize Abzena as the ‘Best Performing R&D Service Provider of the Year’.

Learn More

Abzena announced as best CRO at World ADC awards

Abzena were announced as the winner of the Best Contract Research (CRO) category at the World ADC Awards 2020. The World ADC awards recognise innovation, leadership and devotion in the field of Antibody Drug Conjugates (ADCs) and include nine categories designed to acknowledge the extraordinary work and commercial acumen that companies have demonstrated in order to propel these therapeutics to the forefront of cancer research.

Learn More

Latest News & Insight

Articles

BioPharm International: Optimizing Process Development for Biologics

Read More

Articles

BioPharm International: MHC-Associated Peptide Proteomics – Immunogenicity and Vaccine Design

Read More

Blog

Insights into Development & Regulatory Considerations for Potency Assays

Read More